Wealth Management Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
Wealth Management Associates's BMY Position: Q2 2026 in Review
Wealth Management Associates increased its Bristol-Myers Squibb (BMY) stake by 0.18% in Q2 2026, buying an estimated $402 and bringing the position to 3,965 shares worth $228K. The position accounts for 0.06% of the portfolio, ranked #225.
Wealth Management Associates first reported a position in BMY in Q3 2019 and has held it in 24 quarters since. The position peaked at $607K in Q2 2021. 565 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Wealth Management Associates held 3,965 shares of Bristol-Myers Squibb worth $228K as of Q2 2026.
- Wealth Management Associates bought 7 Bristol-Myers Squibb shares in Q2 2026, an estimated $402.
- Bristol-Myers Squibb made up 0.06% of Wealth Management Associates's portfolio in Q2 2026, its #225 holding.
- Wealth Management Associates first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 24 quarters since.
- Wealth Management Associates's Bristol-Myers Squibb position peaked at $607K in Q2 2021.
- 565 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Wealth Management Associates's 13F filing for Q2 2026, filed 21 Jul 2026.